INTRODUCTION: Sarcopenia likely comprises muscle fiber denervation and re-innervation, resulting in clustering of muscle fibers of the same type (classified by myosin heavy chain isoform composition). Development of methodology to quantitatively evaluate clustering of muscle fibers according to fiber type is necessary. METHODS: Fiber type specific immunofluorescence histology was used to quantify fiber clustering in murine diaphragm muscle (n = 15) at ages 6 and 24 months. RESULTS: With age, fiber type clustering is evidenced by fiber type specific changes in distances between fibers, specifically a 14% decrease to the closest fiber for type I and 24% increase for type IIx and/or IIb fibers (P < 0.001). Additionally, a 34% increase to the 3 closest type IIx and/or IIb fibers was found (P < 0.001). CONCLUSIONS: This novel method of analyzing fiber type clustering may be useful in examining pathophysiological conditions of motor unit loss in neuromuscular disorders, myopathies, dystrophies, injuries, or amyotrophic lateral sclerosis.
INTRODUCTION:Sarcopenia likely comprises muscle fiber denervation and re-innervation, resulting in clustering of muscle fibers of the same type (classified by myosin heavy chain isoform composition). Development of methodology to quantitatively evaluate clustering of muscle fibers according to fiber type is necessary. METHODS: Fiber type specific immunofluorescence histology was used to quantify fiber clustering in murine diaphragm muscle (n = 15) at ages 6 and 24 months. RESULTS: With age, fiber type clustering is evidenced by fiber type specific changes in distances between fibers, specifically a 14% decrease to the closest fiber for type I and 24% increase for type IIx and/or IIb fibers (P < 0.001). Additionally, a 34% increase to the 3 closest type IIx and/or IIb fibers was found (P < 0.001). CONCLUSIONS: This novel method of analyzing fiber type clustering may be useful in examining pathophysiological conditions of motor unit loss in neuromuscular disorders, myopathies, dystrophies, injuries, or amyotrophic lateral sclerosis.
Authors: Sarah M Greising; Carlos B Mantilla; Britney A Gorman; Leonid G Ermilov; Gary C Sieck Journal: Exp Gerontol Date: 2013-06-19 Impact factor: 4.032
Authors: Sarah M Greising; Carlos B Mantilla; Juan S Medina-Martínez; Jessica M Stowe; Gary C Sieck Journal: Am J Physiol Lung Cell Mol Physiol Date: 2015-05-01 Impact factor: 5.464
Authors: Konstantin D Bergmeister; Marion Gröger; Martin Aman; Anna Willensdorfer; Krisztina Manzano-Szalai; Stefan Salminger; Oskar C Aszmann Journal: J Vis Exp Date: 2017-03-28 Impact factor: 1.355
Authors: Hawley E Kunz; Jessica M Dorschner; Taylor E Berent; Thomas Meyer; Xuewei Wang; Aminah Jatoi; Rajiv Kumar; Ian R Lanza Journal: J Biol Chem Date: 2020-10-01 Impact factor: 5.157
Authors: Miguel Pareja-Cajiao; Heather M Gransee; Jessica M Stowe; Sabhya Rana; Gary C Sieck; Carlos B Mantilla Journal: Exp Gerontol Date: 2020-12-05 Impact factor: 4.032
Authors: D G Ohara; M S Pegorari; N L Oliveira Dos Santos; C de Fátima Ribeiro Silva; R L Monteiro; A P Matos; M Jamami Journal: J Nutr Health Aging Date: 2018 Impact factor: 4.075